Ling M R
MedaPhase, Inc., 393 Mill Creek Bend NE, Atlanta, GA 30307, USA.
J Am Acad Dermatol. 1999 Sep;41(3 Pt 2):S13-7. doi: 10.1016/s0190-9622(99)70360-9.
Acitretin is an oral synthetic retinoid effective in the treatment of psoriasis. As monotherapy, acitretin has been shown to be most effective in treating pustular and erythrodermic types of the disease. Monotherapy with acitretin for plaque-type psoriasis is often less successful; however, its use in combination with other therapies is highly effective in treating this form of the disease. Dose-response studies have established the effective dose range of acitretin as well as the dose-dependence of its side effects. Because both efficacy and side effects can vary substantially among individual patients, proper dosing of acitretin requires a balance between optimizing response and minimizing toxicity for each patient. Optimal dosing for individual patients may be achieved through a dose-escalation strategy involving initiation of therapy at low doses (10 to 25 mg/day) and, if necessary, gradually increasing the dose as tolerated until optimal response is achieved.
阿维A是一种口服合成维甲酸,对治疗银屑病有效。作为单一疗法,阿维A已被证明在治疗脓疱型和红皮病型银屑病方面最为有效。阿维A单一疗法治疗斑块型银屑病往往不太成功;然而,它与其他疗法联合使用在治疗这种类型的疾病方面非常有效。剂量反应研究已经确定了阿维A的有效剂量范围及其副作用的剂量依赖性。由于疗效和副作用在个体患者之间可能有很大差异,阿维A的正确给药需要在优化每个患者的反应和最小化毒性之间取得平衡。针对个体患者的最佳给药可通过剂量递增策略实现,该策略包括以低剂量(10至25毫克/天)开始治疗,如有必要,根据耐受情况逐渐增加剂量,直至达到最佳反应。